Hair testing applied to the assessment of in utero exposure to drugs: Critical analysis of 51 cases of the University Hospital of Verona
- PMID: 37154073
- DOI: 10.1002/dta.3515
Hair testing applied to the assessment of in utero exposure to drugs: Critical analysis of 51 cases of the University Hospital of Verona
Abstract
The work discusses the results of hair and urine testing performed in 51 cases of suspected in utero drug exposure handled at the University Hospital of Verona from 2016 to 2022. On the day of birth or the day after birth, urine from mother and newborn (UM and UN) and hair from mother (HM), newborn (HN) and father (HF), if possible, were collected. Urine underwent immunoassay and GC-MS analysis, whereas hair underwent LC-MS/MS and GC-MS/MS analysis. In 50 out of 51 cases, HM and/or HN were available. In 92% of them, hair testing resulted in a positive, often (>50% cases) for more than one class of substance. The most detected substances were cocaine, opiates, methadone and cannabinoids. Maternal segmental analysis showed a prevalent decreasing concentration trend during pregnancy in case of positivity for one class of substances, whereas, as expected, a neatly prevalent increasing trend in the case of positivity for more than one class of substances. In nine cases, HF was also available, resulting in all being positive, usually for the same classes of substances identified in HM, thus questioning parental responsibility. In 33 cases, urine samples from the mother or newborn were also collected. Of them, 27 cases (82%) tested positive, showing peri-partum drug consumption and then confirming the severity of the addiction. Hair testing showed to be a reliable diagnostic tool to investigate in utero drug exposure because of the possibility of obtaining a complete picture of maternal addictive behaviour and family background, thanks to segmental maternal hair analysis and father hair testing.
Keywords: illicit drugs; pregnancy; prenatal exposure; segmental hair analysis.
© 2023 The Authors. Drug Testing and Analysis published by John Wiley & Sons Ltd.
References
REFERENCES
-
- National Institute on Drug Abuse, Substance use while pregnant and breast feeding. Accessed on 27 December 2022. https://nida.nih.gov/publications/research-reports/substance-use-in-wome...
-
- Marchei E, Rotolo MC, Mannocchi G, et al. Assessment of licit and illicit drugs consumption during pregnancy by ultra-high performance liquid chromatography-high resolution mass spectrometry (UHPLC-HRMS) target screening in Mexican women hair. J Pharm Biomed Anal. 2022;211:114607. doi:10.1016/j.jpba.2022.114607
-
- Hetea A, Cosconel C, Stanescu AAM, Simionescu AA. Alcohol and psychoactive drugs in pregnancy. Maedica (Bucur). 2019;14(4):397-401. doi:10.26574/maedica.2019.14.4.397
-
- Minnes S, Lang A, Singer L. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addict Sci Clin Pract. 2011;6(1):57-70.
-
- Barry JM, Birnbaum AK, Jasin LR, Sherwin CM. Maternal exposure and neonatal effects of drugs of abuse. J Clin Pharmacol. 2021;61(Suppl 2):S142-S155. doi:10.1002/jcph.1928
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
